Billionaire Cancer Pioneer Dr. Patrick Soon-Shiong Claims Fauci & Collins Blocked Revolutionary Vaccine
Los Angeles, CA – In a stunning interview with Megan Kelly, Dr. Patrick Soon-Shiong, a renowned cancer researcher and billionaire, has leveled accusations against former National Institutes of Health (NIH) Director Francis Collins and Dr. Anthony Fauci, alleging they actively thwarted the development and implementation of his innovative vaccine platform targeting both COVID-19 and cancer. This breaking news story is sending ripples through the scientific community and raising critical questions about the decision-making processes during the pandemic and beyond. This is a developing story, and Archyde is committed to providing up-to-date coverage.
Dr. Patrick Soon-Shiong, a leading figure in cancer research, claims his vaccine was deliberately sidelined.
The T-Cell Revolution: A New Approach to Immunity
Dr. Soon-Shiong, who made his fortune through breakthroughs in cancer medication and owns the Los Angeles Times, detailed his multi-billion dollar investment in a vaccine designed to activate the body’s T-cells – a crucial component of the immune system. Unlike traditional vaccines that primarily focus on antibody production, Soon-Shiong’s approach aims to create “T-cells that are activated for life,” providing long-lasting immunity. He specifically highlighted a protein called IL-15, the active ingredient in his drug, “Antiva,” which he describes as a naturally occurring immune booster. “God invented it,” he stated, “We illuminated ourselves and found out which switch we need to activate what is in our body.”
The core principle behind this technology isn’t new – harnessing the power of T-cells to fight disease has been a long-sought goal in immunology. However, Soon-Shiong’s claims suggest a viable solution was deliberately ignored. He explained the potential to not only activate T-cells *after* illness but to “train” them proactively, preparing the immune system to recognize and neutralize threats before they take hold. This is particularly promising in conditions like Lynch syndrome, a genetic predisposition to colon cancer, where the vaccine could potentially prevent the disease from developing.
Blocked by the Establishment? Allegations of Suppression
The heart of the controversy lies in Soon-Shiong’s assertion that Fauci and Collins actively opposed his vaccine development. He revealed he invested over $3 billion of his own funds – without relying on government funding – only to see his work stalled. Megan Kelly’s interview with Tucker Carlson, referenced in the discussion, highlighted Soon-Shiong and Carlson’s claim of never having contracted COVID-19, attributing their health to the strength of their T-cells.
Further fueling the controversy, Dr. Soon-Shiong alleges that Dr. Jay Bhattachharjee, the current head of the NIH, was also misled by Collins, who reportedly viewed Soon-Shiong as a threat. He even expressed support for Bobby Kennedy Jr.’s potential leadership at the Department of Health and Human Services, believing a change in leadership is crucial to unlocking the potential of his research. He recounted a previous nomination to lead the NIH during the Trump administration that was allegedly undermined by a smear campaign orchestrated by Collins.
Beyond COVID-19: A Broader War Against Viruses and Cancer
Soon-Shiong’s concerns extend beyond the immediate COVID-19 pandemic. He described the SARS-CoV-2 virus as behaving “like cancer,” infiltrating every part of the body and utilizing it for replication. He warned about the ACE2 receptor, suggesting it could be a vulnerability exploited by the virus and potentially linked to other health issues like lung disease and heart disease. He even offered another molecule, “Ace2,” to a CEO (name withheld) for further development, emphasizing that his motivation is not profit but “a war between the virus and man, and it is about humanity.”
Evergreen Insight: The concept of T-cell immunity is gaining increasing recognition in the scientific community. While mRNA vaccines (like those from Moderna and Pfizer) have proven effective in generating antibody responses, the durability of that immunity is a subject of ongoing research. T-cells offer the potential for longer-lasting protection, and research into T-cell activating therapies is a rapidly growing field. Understanding the nuances of immune responses – both antibody-mediated and T-cell-mediated – is critical for developing effective strategies against future pandemics and chronic diseases like cancer.
A New FDA and a Potential Path Forward?
With a new administration and a new FDA commissioner, Dr. Soon-Shiong expressed cautious optimism that his vaccine might finally receive consideration. He even admitted he was prepared to relinquish his vaccine “just so that they could use it.” The recent full FDA approval of Moderna’s COVID-19 vaccine provides a precedent for expedited review processes, potentially opening a door for other innovative vaccine platforms. The question now is whether the FDA will be willing to re-evaluate Soon-Shiong’s research and consider its potential benefits.
The allegations made by Dr. Soon-Shiong are serious and demand further investigation. Archyde will continue to follow this story closely, providing updates as they become available. The implications of this controversy extend far beyond a single vaccine; they touch upon the integrity of the scientific process, the influence of political pressures, and the future of public health. Stay tuned to Archyde for in-depth reporting and analysis on this critical issue.
Understanding T-cell activation is key to unlocking long-lasting immunity.
